Table 4.

Liposomal formulation categorized on clinical trial phase and applications.

Products	Stage	References
Liposome-stabilized prostate cancer vaccine	Phase I trials	[137]
Liposome-lipid A-prostate-specific antigen formulation	Phase II trials	[137]
Liposomal anthracyclines (pegylated liposomal doxorubicin, nonpegylated liposomal doxorubicin, and liposomal daunorubicin)	Phase I and phase II clinical trials	[138]
CAF01-adjuvant liposomes as vaccine formulation	Phase I trial	[139]
Vascular targeting cationic liposomes encapsulating paclitaxel (EndoTAG-1 [ET]) for human HNSCC (head and neck squamous cell carcinoma).	Phase I/II clinical trial	[140]
The formulation of liposomal peptides vaccines or plasmid–DNA vaccines	in vivo antigen loading	[141]